Replies to post #1122 on Israel-Medical-Healthcare

[genisi]

Andromeda/Teva/Clal DiaPep277 in type I diabetes

The first phase III trial met its primary and secondary endpoints, and was found to be effective and safe.

http://www.globes.co.il/serveen/globes/docview.asp?did=1000699926&fid=1725